Related Experiment Videos
Histocompatibility antigens (HLA) in multiple sclerosis in Iran
Journal of Neurology, Neurosurgery, and Psychiatry
|August 1, 1978
Summary
Multiple sclerosis patients show higher levels of specific Human Leukocyte Antigen (HLA) markers, specifically HLA A3, A11, and B7. These findings suggest a potential genetic link in the development of multiple sclerosis.
Area of Science:
- Immunogenetics
- Neurology
- Human Leukocyte Antigen (HLA) system
Background:
- Multiple sclerosis (MS) is a chronic neurological disease with a complex etiology.
- The Human Leukocyte Antigen (HLA) system plays a crucial role in immune regulation.
- Genetic factors, including HLA associations, are investigated for their role in MS pathogenesis.
Purpose of the Study:
- To investigate the association between specific HLA A and B locus antigens and clinically definite multiple sclerosis.
- To compare HLA antigen frequencies in MS patients versus healthy controls.
- To explore potential correlations between HLA antigens and probable MS cases.
Main Methods:
- Case-control study design.
- Inclusion of 35 patients with clinically definite multiple sclerosis and 100 healthy controls.
- Analysis of HLA A and B locus antigen frequencies in both groups.
Main Results:
- A significant increase in HLA A3 and A11 antigens of the A locus was observed in MS patients compared to controls.
- A significant increase in HLA B7 antigen of the B locus was also noted in MS patients.
- Increased prevalence of HLA A3 was found in eight cases of probable multiple sclerosis.
Conclusions:
- Specific HLA antigens, namely HLA A3, A11, and B7, are significantly associated with an increased risk of developing multiple sclerosis.
- These findings support the hypothesis of a genetic predisposition to MS linked to the HLA system.
- Further research into the immunogenetic mechanisms underlying these associations is warranted.